K Akhilender Naidu (2003). “Vitamin C in human health and disease is still a mystery ? An overview”. Nutrition Journal. doi:10.1186/1475-2891-2-7. PMID14498993.
“Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters.”. The Journal of Clinical Investigation100 (11). (1997). doi:10.1172/JCI119832. PMID9389750.
Hemilä, Harri; Chalker, Elizabeth; Hemilä, Harri (2013). Vitamin C for preventing and treating the common cold. doi:10.1002/14651858.CD000980.pub4.
Cameron E, Campbell A (October 1974). “The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer”. Chem. Biol. Interact.9 (4): 285–315. doi:10.1016/0009-2797(74)90019-2. PMID4430016. "In many of the patients here reported, treatment was initiated in hospital by the continuous intravenous infusion of ascorbic acid for periods up to 10 days."
Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM (January 1985). “High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison”. N. Engl. J. Med.312 (3): 137–41. doi:10.1056/NEJM198501173120301. PMID3880867. "10 g of vitamin C daily or placebo (lactose). Both were prepared in identical opaque gelatin capsules and dispensed in the bottles."
Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S (September 1979). “Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial”. N. Engl. J. Med.301 (13): 687–90. doi:10.1056/NEJM197909273011303. PMID384241.
Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q (February 2014). “High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy”. Sci Transl Med6 (222): 222ra18. doi:10.1126/scitranslmed.3007154. PMID24500406.
Zhao H, Zhu H, Huang J; et al (March 2018). “The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia”. Leuk. Res.66: 1–7. doi:10.1016/j.leukres.2017.12.009. PMID29331774.
GARRY PJ. Nutritional status in a healthy elderly population : vitamin C. Am J Clin Nutr. (1982) vol.36, p.332-339, PMID7102589, doi:10.1093/ajcn/36.2.332
Oreopoulos DG, Lindeman RD, VanderJagt DJ; et al (October 1993). “Renal excretion of ascorbic acid: effect of age and sex”. Journal of the American College of Nutrition12 (5): 537–542. doi:10.1080/07315724.1993.10718349. PMID8263270.
Linster CL, Van Schaftingen E (January 2007). “Vitamin C. Biosynthesis, recycling and degradation in mammals”. The FEBS Journal274 (1): 1–22. doi:10.1111/j.1742-4658.2006.05607.x. PMID17222174.
KC, S.; Carcamo, J. M.; Golde, D. W. (2005). “Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury”. FASEB J.19 (12): 1657–67. doi:10.1096/fj.05-4107com. PMID16195374.
Yun IS, Yoo HS, Kim YO, Rah DK (December 2013). “Improved scar appearance with combined use of silicone gel and vitamin C for Asian patients: a comparative case series”. Aesthetic Plast Surg (6): 1176–81. doi:10.1007/s00266-013-0210-5. PMID24091488.
Liliana Elizabeth Espinal-Perez, Benjamin Moncada, Juan Pablo Castanedo-Cazares (2004-8). “A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma”. International journal of dermatology43 (8): 604–607. doi:10.1111/j.1365-4632.2004.02134.x. PMID15304189.
Hwang, Seon-Wook; Oh, Doo-Jin; Lee, Deborah; et al (2009). “Clinical Efficacy of 25% l-Ascorbic Acid (C'ensil) in the Treatment of Melasma”. Journal of Cutaneous Medicine and Surgery13 (2): 74–81. doi:10.2310/7750.2008.07092. PMID19298775.
Huh, Chang-Hun; Seo, Koo-Il; Park, Je-Young; et al (2003). “A Randomized, Double-Blind, Placebo-Controlled Trial of Vitamin C Iontophoresis in Melasma”. Dermatology206 (4): 316–320. doi:10.1159/000069943. PMID12771472.
Lin, Jing-Yi; Selim, M.Angelica; Shea, Christopher R.; et al (2003). “UV photoprotection by combination topical antioxidants vitamin C and vitamin E”. Journal of the American Academy of Dermatology48 (6): 866–874. doi:10.1067/mjd.2003.425. PMID12789176.
Lin FH, Lin JY, Gupta RD, et al. (October 2005). “Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin”. J. Invest. Dermatol. (4): 826–32. doi:10.1111/j.0022-202X.2005.23768.x. PMID16185284.
Oresajo C, Stephens T, Hino PD, et al. (December 2008). “Protective effects of a topical antioxidant mixture containing vitamin C, ferulic acid, and phloretin against ultraviolet-induced photodamage in human skin”. J Cosmet Dermatol (4): 290–7. doi:10.1111/j.1473-2165.2008.00408.x. PMID19146606.
Pollock JI, Mullin RJ (1987-5). “Vitamin C biosynthesis in prosimians: evidence for the anthropoid affinity of Tarsius”. Am. J. Phys. Anthropol73 (1): 65–70. doi:10.1002/ajpa.1330730106. PMID3113259.
K Akhilender Naidu (2003). “Vitamin C in human health and disease is still a mystery ? An overview”. Nutrition Journal. doi:10.1186/1475-2891-2-7. PMID14498993.
“Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters.”. The Journal of Clinical Investigation100 (11). (1997). doi:10.1172/JCI119832. PMID9389750.
Cameron E, Campbell A (October 1974). “The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer”. Chem. Biol. Interact.9 (4): 285–315. doi:10.1016/0009-2797(74)90019-2. PMID4430016. "In many of the patients here reported, treatment was initiated in hospital by the continuous intravenous infusion of ascorbic acid for periods up to 10 days."
Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM (January 1985). “High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison”. N. Engl. J. Med.312 (3): 137–41. doi:10.1056/NEJM198501173120301. PMID3880867. "10 g of vitamin C daily or placebo (lactose). Both were prepared in identical opaque gelatin capsules and dispensed in the bottles."
Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S (September 1979). “Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial”. N. Engl. J. Med.301 (13): 687–90. doi:10.1056/NEJM197909273011303. PMID384241.
Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q (February 2014). “High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy”. Sci Transl Med6 (222): 222ra18. doi:10.1126/scitranslmed.3007154. PMID24500406.
Zhao H, Zhu H, Huang J; et al (March 2018). “The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia”. Leuk. Res.66: 1–7. doi:10.1016/j.leukres.2017.12.009. PMID29331774.
GARRY PJ. Nutritional status in a healthy elderly population : vitamin C. Am J Clin Nutr. (1982) vol.36, p.332-339, PMID7102589, doi:10.1093/ajcn/36.2.332
Oreopoulos DG, Lindeman RD, VanderJagt DJ; et al (October 1993). “Renal excretion of ascorbic acid: effect of age and sex”. Journal of the American College of Nutrition12 (5): 537–542. doi:10.1080/07315724.1993.10718349. PMID8263270.
Linster CL, Van Schaftingen E (January 2007). “Vitamin C. Biosynthesis, recycling and degradation in mammals”. The FEBS Journal274 (1): 1–22. doi:10.1111/j.1742-4658.2006.05607.x. PMID17222174.
KC, S.; Carcamo, J. M.; Golde, D. W. (2005). “Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury”. FASEB J.19 (12): 1657–67. doi:10.1096/fj.05-4107com. PMID16195374.
S. R. Pinnell, H. Yang, M. Omar; et al (2001-2). “Topical L-ascorbic acid: percutaneous absorption studies”. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]27 (2): 137–142. PMID11207686.
Traikovich SS (October 1999). “Use of topical ascorbic acid and its effects on photodamaged skin topography”. Arch. Otolaryngol. Head Neck Surg. (10): 1091–8. PMID10522500.
Yun IS, Yoo HS, Kim YO, Rah DK (December 2013). “Improved scar appearance with combined use of silicone gel and vitamin C for Asian patients: a comparative case series”. Aesthetic Plast Surg (6): 1176–81. doi:10.1007/s00266-013-0210-5. PMID24091488.
Liliana Elizabeth Espinal-Perez, Benjamin Moncada, Juan Pablo Castanedo-Cazares (2004-8). “A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma”. International journal of dermatology43 (8): 604–607. doi:10.1111/j.1365-4632.2004.02134.x. PMID15304189.
Hayakawa R, Ueda H, Nozaki T; et al (1981). “Effects of combination treatment with vitamins E and C on chloasma and pigmented contact dermatitis. A double blind controlled clinical trial”. Acta vitaminologica et enzymologica3 (1): 31–38. PMID7027767.
Hwang, Seon-Wook; Oh, Doo-Jin; Lee, Deborah; et al (2009). “Clinical Efficacy of 25% l-Ascorbic Acid (C'ensil) in the Treatment of Melasma”. Journal of Cutaneous Medicine and Surgery13 (2): 74–81. doi:10.2310/7750.2008.07092. PMID19298775.
Huh, Chang-Hun; Seo, Koo-Il; Park, Je-Young; et al (2003). “A Randomized, Double-Blind, Placebo-Controlled Trial of Vitamin C Iontophoresis in Melasma”. Dermatology206 (4): 316–320. doi:10.1159/000069943. PMID12771472.
Lin, Jing-Yi; Selim, M.Angelica; Shea, Christopher R.; et al (2003). “UV photoprotection by combination topical antioxidants vitamin C and vitamin E”. Journal of the American Academy of Dermatology48 (6): 866–874. doi:10.1067/mjd.2003.425. PMID12789176.
Lin FH, Lin JY, Gupta RD, et al. (October 2005). “Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin”. J. Invest. Dermatol. (4): 826–32. doi:10.1111/j.0022-202X.2005.23768.x. PMID16185284.
Oresajo C, Stephens T, Hino PD, et al. (December 2008). “Protective effects of a topical antioxidant mixture containing vitamin C, ferulic acid, and phloretin against ultraviolet-induced photodamage in human skin”. J Cosmet Dermatol (4): 290–7. doi:10.1111/j.1473-2165.2008.00408.x. PMID19146606.
Nishikimi M, Kawai T, Yagi K (1992-10). “Guinea pigs possess a highly mutated gene for L-gulono-gamma-lactone oxidase, the key enzyme for L-ascorbic acid biosynthesis missing in this species”. J. Biol. Chem.267 (30): 21967–72. PMID1400507.
Pollock JI, Mullin RJ (1987-5). “Vitamin C biosynthesis in prosimians: evidence for the anthropoid affinity of Tarsius”. Am. J. Phys. Anthropol73 (1): 65–70. doi:10.1002/ajpa.1330730106. PMID3113259.
Friedman TB, Polanco GE, Appold JC, Mayle JE (1985). “On the loss of uricolytic activity during primate evolution--I. Silencing of urate oxidase in a hominoid ancestor”. Comp. Biochem. Physiol., B81 (3): 653?9. PMID3928241.